Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.56 (
insulin-degrading enzyme
)
737
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Insulin degradation is a regulated process that plays a role in controlling insulin action by removing and inactivating the hormone. Abnormalities in insulin clearance and degradation are present in various pathological conditions including type 2 diabetes and obesity and may be important in producing clinical problems. The uptake, processing, and degradation of insulin by cells is a complex process with multiple intracellular pathways. Most evidence supports
IDE
as the primary degradative mechanism, but other systems (PDI, lysosomes, and other enzymes) undoubtedly contribute to insulin metabolism. Recent studies support a multifunctional role for
IDE
, as an intracellular binding, regulatory, and degradative protein.
IDE
increases proteasome and steroid
hormone receptor
activity, and this activation is reversed by insulin. This raises the possibility of a direct intracellular interaction of insulin with
IDE
that could modulate protein and fat metabolism. The recent findings would place intracellular insulin-
IDE
interaction into the insulin signal transduction pathway for mediating the intermediate effects of insulin on fat and protein turnover.
...
PMID:Insulin degradation: progress and potential. 979 60